Short- and long-term stability of SARS-CoV-2 antibodies on dried blood spots under different storage conditions

Dried blood spots (DBS) are currently widely used as a microsampling technique for different qualitative and quantitative serological assessments. Yet, there is a lack of long-term stability and storage condition studies. In our study, first, we assessed the stability of SARS-CoV-2 antibodies on DBS...

Full description

Saved in:
Bibliographic Details
Published inMicrobiology spectrum Vol. 12; no. 12; p. e0111324
Main Authors Meyers, Eline, Coen, Anja, Padalko, Elizaveta, Cools, Piet
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 17.10.2024
Subjects
Online AccessGet full text
ISSN2165-0497
2165-0497
DOI10.1128/spectrum.01113-24

Cover

Abstract Dried blood spots (DBS) are currently widely used as a microsampling technique for different qualitative and quantitative serological assessments. Yet, there is a lack of long-term stability and storage condition studies. In our study, first, we assessed the stability of SARS-CoV-2 antibodies on DBS up to 2 years post-collection. We believe that our data are not only important for future COVID-19 research but also for studies on other infections/diseases using DBS-based serology.
AbstractList Dried blood spots (DBS) are broadly used for different serological analyses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody assessment. In order to biobank DBS samples, an understanding of the preservation of SARS-CoV-2 antibodies is needed. Therefore, we assessed the stability of SARS-CoV-2 antibodies on DBS during short- and long-term storage under different storage temperatures. Seven sample donors were enrolled, each donating twenty 6 mm DBS to assess anti-spike (S1) SARS-CoV-2 IgG antibodies (EUROIMMUN). Baseline samples were analyzed on the day of collection. The remainder of the samples was stored in grip seal bags kept in a cryobox at room temperature/4°C until 2 months after collection and at −20°C until 2 years after collection. Samples were analyzed at regular intervals within the total storage duration and after one and five freeze–thaw cycles. A pooled coefficient of variation was calculated for each storage temperature. We found that anti-S1 SARS-CoV-2 antibodies collected on DBS saver cards remain stable during short-term storage at RT, 4°C, and −20°C (at least to 2 months) and long-term storage at −20°C (at least 2 years). Moreover, up to five freeze–thaw cycles can occur without impacting the anti-S1 SARS-CoV-2 antibody level. The inter-assay coefficient of variation lies between 10 and 15%. As DBS can be preserved for both shorter periods of time at RT and longer periods of time at −20°C, they are a perfect application for studies that require sample shipment by mail, self-sampling studies, studies in limited resource settings and biobanking.IMPORTANCEDried blood spots (DBS) are currently widely used as a microsampling technique for different qualitative and quantitative serological assessments. Yet, there is a lack of long-term stability and storage condition studies. In our study, first, we assessed the stability of SARS-CoV-2 antibodies on DBS up to 2 years post-collection. We believe that our data are not only important for future COVID-19 research but also for studies on other infections/diseases using DBS-based serology.
Dried blood spots (DBS) are broadly used for different serological analyses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody assessment. In order to biobank DBS samples, an understanding of the preservation of SARS-CoV-2 antibodies is needed. Therefore, we assessed the stability of SARS-CoV-2 antibodies on DBS during short- and long-term storage under different storage temperatures. Seven sample donors were enrolled, each donating twenty 6 mm DBS to assess anti-spike (S1) SARS-CoV-2 IgG antibodies (EUROIMMUN). Baseline samples were analyzed on the day of collection. The remainder of the samples was stored in grip seal bags kept in a cryobox at room temperature/4°C until 2 months after collection and at -20°C until 2 years after collection. Samples were analyzed at regular intervals within the total storage duration and after one and five freeze-thaw cycles. A pooled coefficient of variation was calculated for each storage temperature. We found that anti-S1 SARS-CoV-2 antibodies collected on DBS saver cards remain stable during short-term storage at RT, 4°C, and -20°C (at least to 2 months) and long-term storage at -20°C (at least 2 years). Moreover, up to five freeze-thaw cycles can occur without impacting the anti-S1 SARS-CoV-2 antibody level. The inter-assay coefficient of variation lies between 10 and 15%. As DBS can be preserved for both shorter periods of time at RT and longer periods of time at -20°C, they are a perfect application for studies that require sample shipment by mail, self-sampling studies, studies in limited resource settings and biobanking.IMPORTANCEDried blood spots (DBS) are currently widely used as a microsampling technique for different qualitative and quantitative serological assessments. Yet, there is a lack of long-term stability and storage condition studies. In our study, first, we assessed the stability of SARS-CoV-2 antibodies on DBS up to 2 years post-collection. We believe that our data are not only important for future COVID-19 research but also for studies on other infections/diseases using DBS-based serology.Dried blood spots (DBS) are broadly used for different serological analyses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody assessment. In order to biobank DBS samples, an understanding of the preservation of SARS-CoV-2 antibodies is needed. Therefore, we assessed the stability of SARS-CoV-2 antibodies on DBS during short- and long-term storage under different storage temperatures. Seven sample donors were enrolled, each donating twenty 6 mm DBS to assess anti-spike (S1) SARS-CoV-2 IgG antibodies (EUROIMMUN). Baseline samples were analyzed on the day of collection. The remainder of the samples was stored in grip seal bags kept in a cryobox at room temperature/4°C until 2 months after collection and at -20°C until 2 years after collection. Samples were analyzed at regular intervals within the total storage duration and after one and five freeze-thaw cycles. A pooled coefficient of variation was calculated for each storage temperature. We found that anti-S1 SARS-CoV-2 antibodies collected on DBS saver cards remain stable during short-term storage at RT, 4°C, and -20°C (at least to 2 months) and long-term storage at -20°C (at least 2 years). Moreover, up to five freeze-thaw cycles can occur without impacting the anti-S1 SARS-CoV-2 antibody level. The inter-assay coefficient of variation lies between 10 and 15%. As DBS can be preserved for both shorter periods of time at RT and longer periods of time at -20°C, they are a perfect application for studies that require sample shipment by mail, self-sampling studies, studies in limited resource settings and biobanking.IMPORTANCEDried blood spots (DBS) are currently widely used as a microsampling technique for different qualitative and quantitative serological assessments. Yet, there is a lack of long-term stability and storage condition studies. In our study, first, we assessed the stability of SARS-CoV-2 antibodies on DBS up to 2 years post-collection. We believe that our data are not only important for future COVID-19 research but also for studies on other infections/diseases using DBS-based serology.
ABSTRACT Dried blood spots (DBS) are broadly used for different serological analyses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody assessment. In order to biobank DBS samples, an understanding of the preservation of SARS-CoV-2 antibodies is needed. Therefore, we assessed the stability of SARS-CoV-2 antibodies on DBS during short- and long-term storage under different storage temperatures. Seven sample donors were enrolled, each donating twenty 6 mm DBS to assess anti-spike (S1) SARS-CoV-2 IgG antibodies (EUROIMMUN). Baseline samples were analyzed on the day of collection. The remainder of the samples was stored in grip seal bags kept in a cryobox at room temperature/4°C until 2 months after collection and at −20°C until 2 years after collection. Samples were analyzed at regular intervals within the total storage duration and after one and five freeze–thaw cycles. A pooled coefficient of variation was calculated for each storage temperature. We found that anti-S1 SARS-CoV-2 antibodies collected on DBS saver cards remain stable during short-term storage at RT, 4°C, and −20°C (at least to 2 months) and long-term storage at −20°C (at least 2 years). Moreover, up to five freeze–thaw cycles can occur without impacting the anti-S1 SARS-CoV-2 antibody level. The inter-assay coefficient of variation lies between 10 and 15%. As DBS can be preserved for both shorter periods of time at RT and longer periods of time at −20°C, they are a perfect application for studies that require sample shipment by mail, self-sampling studies, studies in limited resource settings and biobanking.IMPORTANCEDried blood spots (DBS) are currently widely used as a microsampling technique for different qualitative and quantitative serological assessments. Yet, there is a lack of long-term stability and storage condition studies. In our study, first, we assessed the stability of SARS-CoV-2 antibodies on DBS up to 2 years post-collection. We believe that our data are not only important for future COVID-19 research but also for studies on other infections/diseases using DBS-based serology.
Dried blood spots (DBS) are currently widely used as a microsampling technique for different qualitative and quantitative serological assessments. Yet, there is a lack of long-term stability and storage condition studies. In our study, first, we assessed the stability of SARS-CoV-2 antibodies on DBS up to 2 years post-collection. We believe that our data are not only important for future COVID-19 research but also for studies on other infections/diseases using DBS-based serology.
Dried blood spots (DBS) are broadly used for different serological analyses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody assessment. In order to biobank DBS samples, an understanding of the preservation of SARS-CoV-2 antibodies is needed. Therefore, we assessed the stability of SARS-CoV-2 antibodies on DBS during short- and long-term storage under different storage temperatures. Seven sample donors were enrolled, each donating twenty 6 mm DBS to assess anti-spike (S1) SARS-CoV-2 IgG antibodies (EUROIMMUN). Baseline samples were analyzed on the day of collection. The remainder of the samples was stored in grip seal bags kept in a cryobox at room temperature/4°C until 2 months after collection and at -20°C until 2 years after collection. Samples were analyzed at regular intervals within the total storage duration and after one and five freeze-thaw cycles. A pooled coefficient of variation was calculated for each storage temperature. We found that anti-S1 SARS-CoV-2 antibodies collected on DBS saver cards remain stable during short-term storage at RT, 4°C, and -20°C (at least to 2 months) and long-term storage at -20°C (at least 2 years). Moreover, up to five freeze-thaw cycles can occur without impacting the anti-S1 SARS-CoV-2 antibody level. The inter-assay coefficient of variation lies between 10 and 15%. As DBS can be preserved for both shorter periods of time at RT and longer periods of time at -20°C, they are a perfect application for studies that require sample shipment by mail, self-sampling studies, studies in limited resource settings and biobanking.IMPORTANCEDried blood spots (DBS) are currently widely used as a microsampling technique for different qualitative and quantitative serological assessments. Yet, there is a lack of long-term stability and storage condition studies. In our study, first, we assessed the stability of SARS-CoV-2 antibodies on DBS up to 2 years post-collection. We believe that our data are not only important for future COVID-19 research but also for studies on other infections/diseases using DBS-based serology.
Dried blood spots (DBS) are broadly used for different serological analyses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody assessment. In order to biobank DBS samples, an understanding of the preservation of SARS-CoV-2 antibodies is needed. Therefore, we assessed the stability of SARS-CoV-2 antibodies on DBS during short- and long-term storage under different storage temperatures. Seven sample donors were enrolled, each donating twenty 6 mm DBS to assess anti-spike (S1) SARS-CoV-2 IgG antibodies (EUROIMMUN). Baseline samples were analyzed on the day of collection. The remainder of the samples was stored in grip seal bags kept in a cryobox at room temperature/4°C until 2 months after collection and at −20°C until 2 years after collection. Samples were analyzed at regular intervals within the total storage duration and after one and five freeze–thaw cycles. A pooled coefficient of variation was calculated for each storage temperature. We found that anti-S1 SARS-CoV-2 antibodies collected on DBS saver cards remain stable during short-term storage at RT, 4°C, and −20°C (at least to 2 months) and long-term storage at −20°C (at least 2 years). Moreover, up to five freeze–thaw cycles can occur without impacting the anti-S1 SARS-CoV-2 antibody level. The inter-assay coefficient of variation lies between 10 and 15%. As DBS can be preserved for both shorter periods of time at RT and longer periods of time at −20°C, they are a perfect application for studies that require sample shipment by mail, self-sampling studies, studies in limited resource settings and biobanking.
Author Padalko, Elizaveta
Coen, Anja
Meyers, Eline
Cools, Piet
Author_xml – sequence: 1
  givenname: Eline
  orcidid: 0000-0002-3549-9548
  surname: Meyers
  fullname: Meyers, Eline
– sequence: 2
  givenname: Anja
  surname: Coen
  fullname: Coen, Anja
– sequence: 3
  givenname: Elizaveta
  surname: Padalko
  fullname: Padalko, Elizaveta
– sequence: 4
  givenname: Piet
  orcidid: 0000-0003-2980-5307
  surname: Cools
  fullname: Cools, Piet
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39417638$$D View this record in MEDLINE/PubMed
BookMark eNp1kUFvFCEUx4mpse3aD-DFcPQyKzDMDHMyzUZtkyYmrnolMLzZspnhrcCY9NuL3bZpD54g8OP3Hu9_Tk4CBiDkHWdrzoX6mA4w5LjMa8Y5ryshX5EzwdumYrLvTp7tT8lFSnvGCsca0Yg35LTuJe_aWp0R3N5izBU1wdEJw67KEGeasrF-8vmO4ki3l9-31QZ_VaJQ2Vt0HhLFQF304KidEB1NB8yJLsFBpM6PI0QIuXgwmh3QAYPz2WNIb8nr0UwJLh7WFfn55fOPzVV18-3r9ebypjK16nJljGpL_9DYkVkrhrYZBNiagWxZ34NUsrdKOGC2GzrZdgKYGcE5ZyVXSo31ilwfvQ7NXh-in02802i8vj_AuNMmZj9MoDtwg7OikaWOHBtjGTfOWFDF3fZQF9eno-uw2LnA5WfRTC-kL2-Cv9U7_KM5b3nflEGvyIcHQ8TfC6SsZ58GmCYTAJeka17i4FJwUdD1ETVpFnqPSwxlTpoz_S91_Zi6vk9dC1kevH_e3VNbjxkXgB-BIWJKEcYn5P_SvwWZv0Y
Cites_doi 10.1128/Spectrum.00178-21
10.4155/bio-2020-0289
10.1093/fampra/cmab094
10.1080/00365540600801645
10.3201/eid2706.210568
10.1080/19485565.2016.1169396
10.1080/21645515.2022.2089498
10.1080/02664760903150706
10.1177/0004563220981106
10.3390/v13060962
10.1371/journal.pone.0248218
10.1002/ansa.202100009
10.1016/j.jcv.2022.105270
10.2807/1560-7917.ES.2023.28.13.2200432
10.1017/S095026882200036X
10.1371/journal.pone.0265813
10.2807/1560-7917.ES.2022.27.13.2100376
10.1002/jmv.21973
10.1515/cclm-2020-1436
10.1093/pubmed/fdab011
10.1016/0166-0934(94)90052-3
10.1038/s41598-022-09699-4
10.1128/mSphere.00490-21
10.1016/j.diagmicrobio.2021.115425
10.1016/j.puhe.2017.08.008
10.1097/QAD.0000000000000348
ContentType Journal Article
Copyright Copyright © 2024 Meyers et al.
Copyright © 2024 Meyers et al. 2024 Meyers et al.
Copyright_xml – notice: Copyright © 2024 Meyers et al.
– notice: Copyright © 2024 Meyers et al. 2024 Meyers et al.
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.1128/spectrum.01113-24
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

CrossRef
PubMed

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2165-0497
Editor Fan, Yi-Chin
Editor_xml – sequence: 1
  givenname: Yi-Chin
  surname: Fan
  fullname: Fan, Yi-Chin
ExternalDocumentID oai_doaj_org_article_7edcdb254b2c4f5ab01adabe8b7c69e3
PMC11619576
spectrum01113-24
39417638
10_1128_spectrum_01113_24
Genre Journal Article
GrantInformation_xml – fundername: Special Research Fund Ghent University
  sequence: 0
  grantid: BOF.COV.2020.0010.01
– fundername: Research Foundation Flanders
  sequence: 0
  grantid: 1SDN2524N
– fundername: ;
  grantid: 1SDN2524N
– fundername: ;
  grantid: BOF.COV.2020.0010.01
GroupedDBID 53G
AAGFI
AAUOK
AAYXX
ADBBV
AGVNZ
ALMA_UNASSIGNED_HOLDINGS
CITATION
EJD
FF~
FRP
GROUPED_DOAJ
H13
M~E
OK1
RPM
RSF
NPM
UCJ
7X8
5PM
ID FETCH-LOGICAL-a387t-aa86165e5bf0bb2c65c2eb30e46099e4849b82de0b7c74672e0afedddb41888f3
IEDL.DBID DOA
ISSN 2165-0497
IngestDate Wed Aug 27 01:29:39 EDT 2025
Thu Aug 21 18:29:18 EDT 2025
Fri Sep 05 07:46:39 EDT 2025
Thu Dec 05 18:27:12 EST 2024
Mon Jul 21 05:35:29 EDT 2025
Tue Jul 01 00:43:00 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords preservation
storage
SARS-CoV-2 antibodies
freeze-thaw
dried blood spots
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. https://creativecommons.org/licenses/by/4.0
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a387t-aa86165e5bf0bb2c65c2eb30e46099e4849b82de0b7c74672e0afedddb41888f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
The authors declare no conflict of interest.
ORCID 0000-0002-3549-9548
0000-0003-2980-5307
OpenAccessLink https://doaj.org/article/7edcdb254b2c4f5ab01adabe8b7c69e3
PMID 39417638
PQID 3117614212
PQPubID 23479
PageCount 8
ParticipantIDs doaj_primary_oai_doaj_org_article_7edcdb254b2c4f5ab01adabe8b7c69e3
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11619576
proquest_miscellaneous_3117614212
asm2_journals_10_1128_spectrum_01113_24
pubmed_primary_39417638
crossref_primary_10_1128_spectrum_01113_24
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20241017
PublicationDateYYYYMMDD 2024-10-17
PublicationDate_xml – month: 10
  year: 2024
  text: 20241017
  day: 17
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: 1752 N St., N.W., Washington, DC
PublicationTitle Microbiology spectrum
PublicationTitleAbbrev Spectrum
PublicationTitleAlternate Microbiol Spectr
PublicationYear 2024
Publisher American Society for Microbiology
Publisher_xml – sequence: 0
  name: American Society for Microbiology
– name: American Society for Microbiology
References e_1_3_5_27_2
e_1_3_5_26_2
e_1_3_5_25_2
e_1_3_5_24_2
e_1_3_5_23_2
e_1_3_5_22_2
e_1_3_5_21_2
Rajna M (e_1_3_5_28_2) 2020
e_1_3_5_2_2
e_1_3_5_8_2
e_1_3_5_20_2
e_1_3_5_7_2
e_1_3_5_9_2
e_1_3_5_4_2
e_1_3_5_3_2
e_1_3_5_6_2
e_1_3_5_5_2
e_1_3_5_17_2
e_1_3_5_16_2
e_1_3_5_15_2
e_1_3_5_14_2
e_1_3_5_12_2
e_1_3_5_13_2
e_1_3_5_10_2
e_1_3_5_11_2
e_1_3_5_19_2
e_1_3_5_18_2
Zava, TT, Zava, DT (B24) 2021; 13
Pryseley, A, Mintiens, K, Knapen, K, Van der Stede, Y, Molenberghs, G (B26) 2010; 37
Anda, EE, Braaten, T, Borch, KB, Nøst, TH, Chen, SLF, Lukic, M, Lund, E, Forland, F, Leon, DA, Winje, BA, Kran, A-M, Kalager, M, Johansen, FL, Sandanger, TM (B16) 2022; 27
Condorelli, F, Scalia, G, Stivala, A, Gallo, R, Marino, A, Battaglini, CM, Castro, A (B17) 1994; 49
Knoop, A, Geyer, H, Lerch, O, Rubio, A, Schrader, Y, Thevis, M (B21) 2021; 2
Reinhardt, B, Taylor, R, Dawkins, C, Banks, T, Watson, N, Sundaram, A, Ewing, D, Danko, JR (B18) 2022; 17
Mariën, J, Ceulemans, A, Bakokimi, D, Lammens, C, Ieven, M, Heytens, S, De Sutter, A, Verbakel, JY, Van den Bruel, A, Goossens, H, Van Damme, P, Ariën, KK, Coenen, S (B13) 2022; 39
Amini, F, Auma, E, Hsia, Y, Bilton, S, Hall, T, Ramkhelawon, L, Heath, PT, Le Doare, K (B3) 2021; 16
Brinc, D, Biondi, MJ, Li, D, Sun, H, Capraru, C, Smookler, D, Zahoor, MA, Casey, J, Kulasingam, V, Feld, JJ (B10) 2021; 13
Wiens, KE, Mawien, PN, Rumunu, J, Slater, D, Jones, FK, Moheed, S, Caflisch, A, Bior, BK, Jacob, IA, Lako, RL (B12) 2021; 27
Rajna, M, Irena, Z, Gyula, M (B27) 2020
Toh, ZQ, Higgins, RA, Anderson, J, Mazarakis, N, Do, LAH, Rautenbacher, K, Ramos, P, Dohle, K, Tosif, S, Crawford, N, Mulholland, K, Licciardi, PV (B8) 2022; 44
Williams, D, Tookey, P, Peckham, CS, Cortina-Borja, M (B20) 2014; 28
Moat, SJ, Zelek, WM, Carne, E, Ponsford, MJ, Bramhall, K, Jones, S, El-Shanawany, T, Wise, MP, Thomas, A, George, C, Fegan, C, Steven, R, Webb, R, Weeks, I, Morgan, BP, Jolles, S (B22) 2021; 58
Eick, G, Urlacher, SS, McDade, TW, Kowal, P, Snodgrass, JJ (B2) 2016; 62
Kaduskar, O, Bhatt, V, Prosperi, C, Hayford, K, Hasan, AZ, Deshpande, GR, Tilekar, B, Vivian Thangaraj, JW, Kumar, MS, Gupta, N, Murhekar, MV, Moss, WJ, Mehendale, SM, Sangal, L, Sapkal, G (B19) 2021; 6
Meyers, E, Heytens, S, Formukong, A, Vercruysse, H, De Sutter, A, Geens, T, Hofkens, K, Janssens, H, Nys, E, Padalko, E, Deschepper, E, Cools, P (B6) 2021; 9
Moat, SJ, Hillier, S, de Souza, S, Perry, M, Cottrell, S, Lench, A, Payne, H, Jolles, S (B11) 2022; 18
Janssens, H, Heytens, S, Meyers, E, De Schepper, E, De Sutter, A, Devleesschauwer, B, Formukong, A, Keirse, S, Padalko, E, Geens, T, Cools, P (B15) 2022; 150
Byström, JW, Vikström, L, Rosendal, E, Gröning, R, Gwon, Y-D, Nilsson, E, Sharma, A, Espaillat, A, Hanke, L, McInerney, G, Puhar, A, Cava, F, Karlsson Hedestam, GB, Thunberg, T, Monsen, T, Elgh, F, Evander, M, Johansson, AF, Överby, AK, Ahlm, C, Normark, J, Forsell, MN (B14) 2023; 28
Miesse, PK, Collier, BB, Grant, RP (B25) 2022; 12
Sarge-Njie, R, Schim Van Der Loeff, M, Ceesay, S, Cubitt, D, Sabally, S, Corrah, T, Whittle, H (B5) 2006; 38
Meyers, E, Coen, A, De Sutter, A, Padalko, E, Callens, S, Vandekerckhove, L, Witkowski, W, Heytens, S, Cools, P (B7) 2022; 155
Turgeon, CT, Sanders, KA, Granger, D, Nett, SL, Hilgart, H, Matern, D, Theel, ES (B23) 2021; 101
Muzembo, BA, Mbendi, NC, Nakayama, SF (B1) 2017; 153
Melgaço, JG, Pinto, MA, Rocha, AM, Freire, M, Gaspar, LP, Lima, SMB, Cruz, OG, Vitral, CL (B4) 2011; 83
Weisser, H, Steinhagen, K, Höcker, R, Borchardt-Lohölter, V, Anvari, Ö, Kern, PM (B9) 2021; 59
References_xml – ident: e_1_3_5_7_2
  doi: 10.1128/Spectrum.00178-21
– ident: e_1_3_5_25_2
  doi: 10.4155/bio-2020-0289
– ident: e_1_3_5_14_2
  doi: 10.1093/fampra/cmab094
– ident: e_1_3_5_6_2
  doi: 10.1080/00365540600801645
– ident: e_1_3_5_13_2
  doi: 10.3201/eid2706.210568
– ident: e_1_3_5_3_2
  doi: 10.1080/19485565.2016.1169396
– volume-title: Norovirus
  year: 2020
  ident: e_1_3_5_28_2
– ident: e_1_3_5_12_2
  doi: 10.1080/21645515.2022.2089498
– ident: e_1_3_5_27_2
  doi: 10.1080/02664760903150706
– ident: e_1_3_5_23_2
  doi: 10.1177/0004563220981106
– ident: e_1_3_5_11_2
  doi: 10.3390/v13060962
– ident: e_1_3_5_4_2
  doi: 10.1371/journal.pone.0248218
– ident: e_1_3_5_22_2
  doi: 10.1002/ansa.202100009
– ident: e_1_3_5_8_2
  doi: 10.1016/j.jcv.2022.105270
– ident: e_1_3_5_15_2
  doi: 10.2807/1560-7917.ES.2023.28.13.2200432
– ident: e_1_3_5_16_2
  doi: 10.1017/S095026882200036X
– ident: e_1_3_5_19_2
  doi: 10.1371/journal.pone.0265813
– ident: e_1_3_5_17_2
  doi: 10.2807/1560-7917.ES.2022.27.13.2100376
– ident: e_1_3_5_5_2
  doi: 10.1002/jmv.21973
– ident: e_1_3_5_10_2
  doi: 10.1515/cclm-2020-1436
– ident: e_1_3_5_9_2
  doi: 10.1093/pubmed/fdab011
– ident: e_1_3_5_18_2
  doi: 10.1016/0166-0934(94)90052-3
– ident: e_1_3_5_26_2
  doi: 10.1038/s41598-022-09699-4
– ident: e_1_3_5_20_2
  doi: 10.1128/mSphere.00490-21
– ident: e_1_3_5_24_2
  doi: 10.1016/j.diagmicrobio.2021.115425
– ident: e_1_3_5_2_2
  doi: 10.1016/j.puhe.2017.08.008
– ident: e_1_3_5_21_2
  doi: 10.1097/QAD.0000000000000348
– volume: 17
  year: 2022
  ident: B18
  article-title: The use of dried blood spot cards to assess serologic responses of individuals vaccinated against measles, hepatitis A, tetanus, influenza and varicella zoster
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0265813
– volume: 6
  year: 2021
  ident: B19
  article-title: Optimization and stability testing of four commercially available dried blood spot devices for estimating measles and rubella IgG antibodies
  publication-title: mSphere
  doi: 10.1128/mSphere.00490-21
– volume: 58
  start-page: 123
  year: 2021
  end-page: 131
  ident: B22
  article-title: Development of a high-throughput SARS-CoV-2 antibody testing pathway using dried blood spot specimens
  publication-title: Ann Clin Biochem
  doi: 10.1177/0004563220981106
– volume: 27
  year: 2022
  ident: B16
  article-title: Seroprevalence of antibodies against SARS-CoV-2 in the adult population during the pre-vaccination period, Norway, winter 2020/21
  publication-title: Euro Surveill
  doi: 10.2807/1560-7917.ES.2022.27.13.2100376
– volume: 101
  start-page: 115425
  year: 2021
  ident: B23
  article-title: Detection of SARS-CoV-2 IgG antibodies in dried blood spots
  publication-title: Diagn Microbiol Infect Dis
  doi: 10.1016/j.diagmicrobio.2021.115425
– year: 2020
  ident: B27
  article-title: Optimization, validation and standardization of ELISA, p Ch. 2
  publication-title: Norovirus ;In ;IntechOpen ;Rijeka
– volume: 38
  start-page: 1050
  year: 2006
  end-page: 1056
  ident: B5
  article-title: Evaluation of the dried blood spot filter paper technology and five testing strategies of HIV-1 and HIV-2 infections in West Africa
  publication-title: Scand J Infect Dis
  doi: 10.1080/00365540600801645
– volume: 28
  start-page: 1850
  year: 2014
  end-page: 1851
  ident: B20
  article-title: Long-term stability of HIV-1 antibody in dried blood spot samples and eluates
  publication-title: AIDS
  doi: 10.1097/QAD.0000000000000348
– volume: 153
  start-page: 128
  year: 2017
  end-page: 136
  ident: B1
  article-title: Systematic review with meta-analysis: performance of dried blood spots for hepatitis C antibodies detection
  publication-title: Public Health
  doi: 10.1016/j.puhe.2017.08.008
– volume: 155
  start-page: 105270
  year: 2022
  ident: B7
  article-title: Diagnostic performance of the SARS-CoV-2 S1RBD IgG ELISA (ImmunoDiagnostics) for the quantitative detection of SARS-CoV-2 antibodies on dried blood spots
  publication-title: J Clin Virol
  doi: 10.1016/j.jcv.2022.105270
– volume: 13
  start-page: 13
  year: 2021
  end-page: 28
  ident: B24
  article-title: Validation of dried blood spot sample modifications to two commercially available COVID-19 IgG antibody immunoassays
  publication-title: Bioanalysis
  doi: 10.4155/bio-2020-0289
– volume: 13
  year: 2021
  ident: B10
  article-title: Evaluation of dried blood spot testing for SARS-CoV-2 serology using a quantitative commercial assay
  publication-title: Viruses
  doi: 10.3390/v13060962
– volume: 62
  start-page: 222
  year: 2016
  end-page: 233
  ident: B2
  article-title: Validation of an optimized ELISA for quantitative assessment of Epstein-Barr virus antibodies from dried blood spots
  publication-title: Biodemogr Soc Biol
  doi: 10.1080/19485565.2016.1169396
– volume: 28
  year: 2023
  ident: B14
  article-title: At-home sampling to meet geographical challenges for serological assessment of SARS-CoV-2 exposure in a rural region of northern Sweden, March to May 2021: a retrospective cohort study
  publication-title: Euro Surveill
  doi: 10.2807/1560-7917.ES.2023.28.13.2200432
– volume: 9
  year: 2021
  ident: B6
  article-title: Comparison of dried blood spots and venous blood for the detection of SARS-CoV-2 antibodies in a population of nursing home residents
  publication-title: Microbiol Spectr
  doi: 10.1128/Spectrum.00178-21
– volume: 16
  year: 2021
  ident: B3
  article-title: Reliability of dried blood spot (DBS) cards in antibody measurement: a systematic review
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0248218
– volume: 49
  start-page: 25
  year: 1994
  end-page: 36
  ident: B17
  article-title: Detection of immunoglobulin G to measles virus, rubella virus, and mumps virus in serum samples and in microquantities of whole blood dried on filter paper
  publication-title: J Virol Methods
  doi: 10.1016/0166-0934(94)90052-3
– volume: 37
  start-page: 1729
  year: 2010
  end-page: 1747
  ident: B26
  article-title: Estimating precision, repeatability, and reproducibility from Gaussian and non- Gaussian data: a mixed models approach
  publication-title: J Appl Stat
  doi: 10.1080/02664760903150706
– volume: 44
  start-page: e260
  year: 2022
  end-page: e263
  ident: B8
  article-title: The use of dried blood spots for the serological evaluation of SARS-CoV-2 antibodies
  publication-title: J Public Health (Bangkok)
  doi: 10.1093/pubmed/fdab011
– volume: 18
  year: 2022
  ident: B11
  article-title: Maternal SARS-CoV-2 sero-surveillance using newborn dried blood spot (DBS) screening specimens highlights extent of low vaccine uptake in pregnant women
  publication-title: Hum Vaccin Immunother
  doi: 10.1080/21645515.2022.2089498
– volume: 39
  start-page: 92
  year: 2022
  end-page: 98
  ident: B13
  article-title: Prospective SARS-CoV-2 cohort study among primary health care providers during the second COVID-19 wave in Flanders, Belgium
  publication-title: Fam Pract
  doi: 10.1093/fampra/cmab094
– volume: 27
  start-page: 1598
  year: 2021
  end-page: 1606
  ident: B12
  article-title: Seroprevalence of severe acute respiratory syndrome Coronavirus 2 IgG in Juba, South Sudan, 2020
  publication-title: Emerg Infect Dis
  doi: 10.3201/eid2706.210568
– volume: 2
  start-page: 440
  year: 2021
  end-page: 446
  ident: B21
  article-title: Detection of anti-SARS-CoV-2 antibodies in dried blood spots utilizing manual or automated spot extraction and electrochemiluminescence immunoassay (ECLIA)
  publication-title: Anal Sci Adv
  doi: 10.1002/ansa.202100009
– volume: 83
  start-page: 208
  year: 2011
  end-page: 217
  ident: B4
  article-title: The use of dried blood spots for assessing antibody response to hepatitis A virus after natural infection and vaccination
  publication-title: J Med Virol
  doi: 10.1002/jmv.21973
– volume: 150
  year: 2022
  ident: B15
  article-title: Pre-vaccination SARS-CoV-2 seroprevalence among staff and residents of nursing homes in Flanders (Belgium) in fall 2020
  publication-title: Epidemiol Infect
  doi: 10.1017/S095026882200036X
– volume: 59
  start-page: 979
  year: 2021
  end-page: 985
  ident: B9
  article-title: Evaluation of dried blood spots as alternative sampling material for serological detection of anti-SARS-CoV-2 antibodies using established ELISAs
  publication-title: Clin Chem Lab Med
  doi: 10.1515/cclm-2020-1436
– volume: 12
  year: 2022
  ident: B25
  article-title: Monitoring of SARS-CoV-2 antibodies using dried blood spot for at-home collection
  publication-title: Sci Rep
  doi: 10.1038/s41598-022-09699-4
SSID ssj0001105252
Score 2.327038
Snippet Dried blood spots (DBS) are currently widely used as a microsampling technique for different qualitative and quantitative serological assessments. Yet, there...
Dried blood spots (DBS) are broadly used for different serological analyses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody...
ABSTRACT Dried blood spots (DBS) are broadly used for different serological analyses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)...
SourceID doaj
pubmedcentral
proquest
asm2
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage e0111324
SubjectTerms dried blood spots
freeze-thaw
Immunology
preservation
Research Article
SARS-CoV-2 antibodies
storage
SummonAdditionalLinks – databaseName: American Society for Microbiology Open Access
  dbid: AAUOK
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fa9UwFD7MOwRfZPNnN5UIgiBkNmmSpo_XsTEUFbxe2VtImnQbuFZ2u4f99ztJ26tXhvjapKTJl5zzfc1JDsAbFeoGiXJOywZNIFpJSyspHBVVXTqp6qpOaTo_f1EnS_HxVJ5ugZrOwowjuDqwq8u0kb9e2Vy_T4cPr64vD1KCdMrFPdiW6K_4DLbn8-XXT7__rrCYn42P25h3vos2GNvgG_4oXdt_F9f8O2TyDx90vAMPR_JI5gPau7AV2kdwf0gnefMYusU5kmlKbOvJz649o9HsEqR_KQD2hnQNWcy_Lehh94NyrNVfuC4GEZKuJR4lsycpjJ2g0u1XJJ4uuyJTApWexDBKND4EBbQf4ryewPL46PvhCR0TKlBb6LKn1mrFlAzSNblzvFay5iim8yAUEsUgtKic5j7krqxjGhIectsE770TDJVyUzyFWdu14TkQL0ofghVBFUw4VjlnPc-D1I3glvOQwds4umbC0ySxwbWZcDAJB8NFBu8mAMyv4YaNf1X-ECFaV4yXY6cHOFXMuNZMiTB5h8oXuygaaV3OrLcuaOyWqkKRwesJYIOLKe6Q2DZ01ytTMFYiX0F3nsGzAfB1U0UlsLDQGeiNqbDxLZsl7cV5urCbIa2uUNjt_feg7MMDjuwpOklWvoAZFoaXyH5692qc6rfx5AYn
  priority: 102
  providerName: American Society for Microbiology
Title Short- and long-term stability of SARS-CoV-2 antibodies on dried blood spots under different storage conditions
URI https://www.ncbi.nlm.nih.gov/pubmed/39417638
https://journals.asm.org/doi/10.1128/spectrum.01113-24
https://www.proquest.com/docview/3117614212
https://pubmed.ncbi.nlm.nih.gov/PMC11619576
https://doaj.org/article/7edcdb254b2c4f5ab01adabe8b7c69e3
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3faxQxEA5yIvgi_nbVlgiCIMQm2Ww2eTyLpSgqeJ70LSSb2bZgd6W3feh_7yS7V-6KtC--bgIbZpKZ79udzEfIWw1Ni0CZs7rFEIhR0jNbqcCUbepQ6cY2Wabz6zd9uFSfj6qjDamvVBM2tgceDbdXQ2xiQBoTZKPaygcufPQBTKgbbSH3-eSWb5Cp_HVFJH02Of3GxBi8ly8unl-cfcji6izdcJ_51Zncyke5bf-_sOb1ksmNHHTwkDyYwCOdj4t-RO5A95jcG-UkL5-QfnGCYJpR30X6u--OWQq7FOFfLoC9pH1LF_MfC7bf_2ISZw2noU9FhLTvaETKHGkuY6fIdIcVTbfLzulaQGWgqYwSgw9FAh3HOq-nZHnw6ef-IZsEFZgvTT0w740WuoIqtDygPXXVSCTTHJRGoAjKKBuMjMDRtkmGRAL3LcQYgxLIlNvyGZl1fQcvCI2qjgBegS6FCsKG4KPkUJlWSS8lFORdsq6bTsTKZbIhjVv7wWU_OKkK8n7tAPdn7LBx0-SPyUVXE1Nz7PwAt4ybtoy7bcsU5M3awQ4PU_pD4jvoL1auFKJGvILpvCDPR4dfvaq0CgdLUxCztRW21rI90p2e5IbdAmG1RWL38n-s_hW5LxFYpfwp6tdkhvaBHQRGQ9gld-fz5fcvu_ks_AXIXxKJ
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB7BVgguiGcJTyMhISG5jR3HcY7bimqhDyS2i3qz7Nhpi9oENemh_56xk21ZVCGu8UROPPb4G894PoAP0lc1AuWUFjWaQLSShpa5sFSUVWFzWZVVpOncP5Czhfh6lB-NWZXhLszPwMt71m2Y7jzG8cPCDgfRIx-h2owXEC8uzzciSTrl4i6shWCVmsDadLr4tntzwsICRxsfQ5m3vot2GDviK3tSLN1_G978O23yj31o5xE8HAEkmQ4afwx3fPME7g2UkldPoZ2fIKCmxDSOnLXNMQ2mlyAEjEmwV6StyXz6fU632x-Uo1R_atuQSEjahjh0mx2JqewEvd2-I-GG2QVZkqj0JKRSogEi6ES7IdfrGSx2Ph9uz-hIqkBNpoqeGqMkk7nPbZ1ayyuZVxwd6tQLiWDRCyVKq7jzqS2qQEXCfWpq75yzgqG3XGfPYdK0jX8BxInCeW-ElxkTlpXWGsdTn6tacMO5T-BjGF09ropOR4eDK73Ug4560Fwk8GmpAP1rqLLxL-GtoKJrwVAgOz7A-aLH9aYLVJOz6P3iL4o6NzZlxhnrFf6WLH2WwPulgjUuqBAlMY1vLzudMVYgZsEtPYH1QeHXXWWlwMZMJaBWpsLKt6y2NKcnsWg3Q2hdonP38r8H5R3cnx3u7-m9Lwe7r-ABRzQVNk1WvIYJCvo3iIZ6-3ac9r8BU88Kig
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Nb9QwEB3BViAuiM-SQsFISEhIbmPHTpzj0rIqFApiWdSbZcdOW6lNqm566L9n7CSFRRXiGk_k2M-eeROPZwDe5L6qkSintKhRBaKWNLSUwlJRVoWVeVVWsUznl4N8byE-HcrDIaoy3IUZZnC5ZZZn8SA_7OxzVw_1CNV2vIB4cXm2FYukUy5uw5rkpZATWJtOF1_3f_9hYaFGGx-OMm98F_Uw9sNXbFJM3X8T3_w7bPIPOzR7APcHAkmmPeIP4ZZvHsGdvqTk1WNo58dIqCkxjSOnbXNEg-olSAFjEOwVaWsyn36f0532J-Uo1Z3YNgQSkrYhDt1mR2IoO0Fvt1uScMPsgoxFVDoSQilRARF0ol0f6_UEFrMPP3b26FBUgZpMFR01RuUsl17aOrWWV7msODrUqRc5kkUvlCit4s6ntqhCKRLuU1N755wVDL3lOnsKk6Zt_DMgThTOeyN8njFhWWmtcTz1UtWCG859Am_D7OoRUx0dDq70iIOOOGguEng3AqDP-ywb_xJ-HyC6FgwJsuMDXC562G-6QJicRe8XhyhqaWzKjDPWKxxWXvosgdcjwBo3VDglMY1vL5c6Y6xAzoImPYH1HvDrrrJSYGOmElArS2HlW1ZbmpPjmLSbIbUu0bnb-O9JeQV3v-3O9OePB_vP4R5HMhVsJitewATl_CaSoc6-HFb9LyzfCiY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Short-+and+long-term+stability+of+SARS-CoV-2+antibodies+on+dried+blood+spots+under+different+storage+conditions&rft.jtitle=Microbiology+spectrum&rft.au=Eline+Meyers&rft.au=Anja+Coen&rft.au=Elizaveta+Padalko&rft.au=Piet+Cools&rft.date=2024-10-17&rft.pub=American+Society+for+Microbiology&rft.eissn=2165-0497&rft.volume=12&rft.issue=12&rft_id=info:doi/10.1128%2Fspectrum.01113-24&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_7edcdb254b2c4f5ab01adabe8b7c69e3
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2165-0497&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2165-0497&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2165-0497&client=summon